Perceptions in transfusion medicine: A pilot field study on risk and ethics for blood and blood substitutes

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 35, Issue 2, 2007, Pages 149-156

  Fleming, Piers ^a   Ferguson, Eamonn ^a   Townsend, Ellen ^a   Lowe, Kenneth C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BLOOD; BLOOD SUBSTITUTES; GROWTH KINETICS; MEDICAL PROBLEMS; PATIENT TREATMENT;

BLOOD DONATION; BLOOD TRANSFUSION; HYPOTHETICAL TRANSFUSION;

HEALTH RISKS;

ARTIFICIAL BLOOD; BLOOD SUBSTITUTE; RECOMBINANT HEMOGLOBIN;

ADULT; ARTICLE; BACTERIUM; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; COW; FEMALE; HUMAN; MALE; MEDICAL ETHICS; PILOT STUDY; PUBLIC OPINION; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; STANDARD; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; ANIMALS; BLOOD DONORS; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; CATTLE; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PUBLIC OPINION; QUESTIONNAIRES; RISK FACTORS;

BOVINAE;

EID: 34047118676     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.1080/10731190601188216     Document Type: Article

References (23)

1. Lowe, K.C., Ferguson, E. (2003). Benefit and risk perceptions in transfusion medicine: blood and blood substitutes. Journal of Internal Medicine 253: 498-507.
2. Matheson, B., Raznaka, A., Kwansa, H., Bucci, E. (2002). Vascular response to infusions of a nonextravasating hemoglobin polymer. Journal of Applied Physiology 93: 1479-1486.
3. Niiler, E. (2002). Setbacks for blood substitute companies. Nature Biotechnology 20: 962-963.
4. Chang, T.M.S. (2003). Future generations of red blood cell substitutes. Journal of Internal Medicine 253: 527-535.
5. Chang, T.M.S. (2004). Hemoglobin-based red blood cell substitutes. Artificial Organs 28: 789-794.
6. Chang, T.M.S. (2005). Therapeutic applications of polymeric artificial cells. Nature Reviews Drug Discovery 4: 221-235.
7. Lowe, K.C. (2003). Engineering blood: synthetic substitutes from fluorinated compounds. Tissue Engineering 9: 389-399.
8. Lowe, K.C. (2006). Blood substitutes: from chemistry to clinic. Journal of Materials Chemistry 16: 1-9.
9. Vandegriff, K.D., Malavalli, A., Woodridge, J., Lohman, J., Winslow, R. (2003). MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 43: 509-516.
10. Winslow, R.M. (2003). Current status of blood substitute research: towards a new paradigm. Journal of Internal Medicine 253: 508-517.
11. Alayash, A.I. (2004). Oxygen therapeutics: can we tame haemoglobin? Nature Reviews 3: 152-159.
12. Buehler, P.W., Alayash, A.I. (2004). Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems. Transfusion 44: 1516-1530.
13. Finucane, M., Slovic, P., Mertz, C. (2000). Public perception of the risk of blood transfusion. Transfusion 40: 1017-1022.
14. Farrell, K., Ferguson, E.M.P., James, V., Lowe, K.C. (2001). Confidence in the safety of blood for transfusion: the effect of message framing. Transfusion 41: 1335-1340.
15. Ferguson, E.M.P., Farrell, K., Lowe, K.C., James, V. (2001). Perception of risk of blood transfusion: knowledge, group membership and perceived control. Transfusion Medicine 11: 129-135.
16. Ferguson, E., Farrell, K., James, V., Lowe, K.C. (2004). Trustworthiness of information about blood donation and transfusion in relation to knowledge and perceptions of risk: an analysis of UK stakeholder groups. Transfusion Medicine 14: 205-216.
17. Lowe, K.C., Farrell, K., Ferguson, E.M.P., James, V. (2001). Current perceived risks of transfusion in the UK and relevance to the future acceptance of blood substitutes. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 29: 179-189.
18. Ferguson, E., Leaviss, J., Townsend, E., Fleming, P., Lowe, K.C. (2005). Perceived safety of donor blood and blood substitutes for transfusion: the role of informational frame, patient groups and stress appraisals. Transfusion Medicine 15: 401-412.
19. Verhoog, H. (2003). Naturalness and the genetic modification of animals. Trends in Biotechnology 21: 294-297.
20. Fischhoff, B., Slovic, P., Lichtenstein, S., Read, S., Combs, B. (1978). How safe is safe enough? A psychometric study of attitudes towards technological risks and benefits. Policy Sciences 9: 127-152.
21. Alhakami, A.S., Slovic, P. (1994). A psychological study of the inverse relationship between perceived risk and perceived benefit. Risk Analysis 14: 1085-1096.
22. Grant, F.C., Laupacis, A., O'Connor, A.M., Rubens, F., Robblee, J. (2001). Evaluation of a decision aid for patients considering autologous blood donation before open-heart surgery. Canadian Medical Association Journal 164: 1139-1144.
23. Lee, D.H., Mehta, M.D. (2003). Evaluation of a visual risk communication tool: effects on knowledge and perception of blood transfusion risk. Transfusion 43: 779-787.